David Moradi Net Worth & Insider Trades

David Moradi - Director, Kalobios Pharmaceuticals Inc

As of December 17, 2015

What is David Moradi's Net Worth?

The current estimated net worth of Kalobios Pharmaceuticals Inc's Director, David Moradi, is estimated to be about $12.26M . David Moradi owns about 778,210 units of Kalobios Pharmaceuticals Inc common stock. In the last month at Kalobios Pharmaceuticals Inc, David Moradi has sold an estimated value of $0 worth.

What is David Moradi's Past Insider Trading?

David Moradi's largest purchase order was 300,000 units , worth over $639K on November 19, 2015. In total, David Moradi has made about 2 transactions over a month of their time at Kalobios Pharmaceuticals Inc. David Moradi usually trades in November and December, with the busiest year in 2015. The most recent transaction was a purchase order of 6,820 units , worth over $199.96K on December 17, 2015.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Anthion Partners II LLC, David Moradi

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is David Moradi's' Mailing Address?

  • Mailing address is 379 West Broadway New York NY 10021 NY

What are Kalobios Pharmaceuticals Inc's Past Insider Trades?

Kalobios Pharmaceuticals Inc's most recent insider trade came on August 29, 2016 by Martin Shkreli who sold 2,222,929 units worth $6.89M . In the last 3 years, insiders at Kalobios Pharmaceuticals Inc have sold an estimated value of $6.89M and bought an estimated value of $10.22M worth of shares. Insider trading is most common in February, with the busiest year in 2015. The most active traders at the company are Herb Cross, Chief Financial Officer,  Ron Martell, Executive Chairman,  and Martin Shkreli .

KALOBIOS PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...